Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Which specific modes of exercise training are most effective for treating low back pain? Network meta-analysis.

Owen PJ, Miller CT, Mundell NL, Verswijveren SJ, Tagliaferri SD, Brisby H, Bowe SJ, Belavy DL.

Br J Sports Med. 2019 Oct 30. pii: bjsports-2019-100886. doi: 10.1136/bjsports-2019-100886. [Epub ahead of print] Review.

2.

Domains of Chronic Low Back Pain and Assessing Treatment Effectiveness: A Clinical Perspective.

Tagliaferri SD, Miller CT, Owen PJ, Mitchell UH, Brisby H, Fitzgibbon B, Masse-Alarie H, Van Oosterwijck J, Belavy DL.

Pain Pract. 2019 Oct 14. doi: 10.1111/papr.12846. [Epub ahead of print] Review.

PMID:
31610090
3.

Incidence of toxoplasmosis in pregnancy in Campania: A population-based study on screening, treatment, and outcome.

Donadono V, Saccone G, Maruotti GM, Berghella V, Migliorini S, Esposito G, Sirico A, Tagliaferri S, Ward A, Mazzarelli LL, Sarno L, Agangi A, Quaglia F, Zullo F, Martinelli P.

Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:316-321. doi: 10.1016/j.ejogrb.2019.07.033. Epub 2019 Jul 25.

PMID:
31404785
4.

Proactive interception and care of Frailty and Multimorbidity in older persons: the experience of the European Innovation Partnership on Active and Healthy Ageing and the response of Parma Local Health Trust and Lab through European Projects.

Longobucco Y, Benedetti C, Tagliaferri S, Angileri VV, Adorni E, Pessina M, Zerbinati L, Cicala L, Pelà G, Giacomini V, Barbolini M, Lauretani F, Maggio MG.

Acta Biomed. 2019 May 23;90(2):364-374. doi: 10.23750/abm.v90i2.8419.

5.

Fetal heart rate monitoring and neonatal outcome in a population of early- and late-onset intrauterine growth restriction.

Esposito FG, Tagliaferri S, Giudicepietro A, Giuliano N, Maruotti GM, Saccone G, Signorini MG, Magenes G, Campanile M, Zullo F.

J Obstet Gynaecol Res. 2019 Jul;45(7):1343-1351. doi: 10.1111/jog.13981. Epub 2019 May 16.

PMID:
31099119
6.

Testing the deconditioning hypothesis of low back pain: A study in 1182 older women.

Tagliaferri SD, Armbrecht G, Miller CT, Owen PJ, Mundell NL, Felsenberg D, Thomasius F, Belavy DL.

Eur J Sport Sci. 2019 Apr 23:1-7. doi: 10.1080/17461391.2019.1606942. [Epub ahead of print]

PMID:
31012382
7.

The risk of dysphagia is associated with malnutrition and poor functional outcomes in a large population of outpatient older individuals.

Tagliaferri S, Lauretani F, Pelá G, Meschi T, Maggio M.

Clin Nutr. 2019 Dec;38(6):2684-2689. doi: 10.1016/j.clnu.2018.11.022. Epub 2018 Nov 30.

8.

Intrapartum cardiotocography with and without computer analysis: a systematic review and meta-analysis of randomized controlled trials.

Campanile M, D'Alessandro P, Della Corte L, Saccone G, Tagliaferri S, Arduino B, Esposito G, Esposito FG, Raffone A, Signorini MG, Magenes G, Di Tommaso M, Xodo S, Zullo F, Berghella V.

J Matern Fetal Neonatal Med. 2018 Nov 18:1-7. doi: 10.1080/14767058.2018.1542676. [Epub ahead of print]

PMID:
30449222
9.

The controversial role of vitamin D as an antioxidant: results from randomised controlled trials.

Tagliaferri S, Porri D, De Giuseppe R, Manuelli M, Alessio F, Cena H.

Nutr Res Rev. 2019 Jun;32(1):99-105. doi: 10.1017/S0954422418000197. Epub 2018 Oct 17.

PMID:
30326975
10.

Deinococcus radiodurans' SRA-HNH domain containing protein Shp (Dr1533) is involved in faithful genome inheritance maintenance following DNA damage.

Ferrandi A, Castani F, Pitaro M, Tagliaferri S, de la Tour CB, Alduina R, Sommer S, Fasano M, Barbieri P, Mancini M, Bonapace IM.

Biochim Biophys Acta Gen Subj. 2019 Jan;1863(1):118-129. doi: 10.1016/j.bbagen.2018.09.020. Epub 2018 Oct 9.

PMID:
30308220
11.

Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.

Corsonello A, Lattanzio F, Bustacchini S, Garasto S, Cozza A, Schepisi R, Lenci F, Luciani F, Maggio MG, Ticinesi A, Butto V, Tagliaferri S, Corica F.

Curr Drug Metab. 2018;19(2):142-154. doi: 10.2174/1389200219666171207125351. Review.

PMID:
29219052
12.

Ethnic analogies and differences in fetal heart rate variability signal: A retrospective study.

Tagliaferri S, Esposito FG, Fagioli R, Di Cresce M, Sacchi L, Signorini MG, Campanile M, Martinelli P, Magenes G.

J Obstet Gynaecol Res. 2017 Feb;43(2):281-290. doi: 10.1111/jog.13213. Epub 2016 Dec 17.

PMID:
27987340
13.

Computerised analysis of antepartum foetal heart parameters: New reference ranges.

Giuliano N, Annunziata ML, Esposito FG, Tagliaferri S, Di Lieto A, Magenes G, Signorini MG, Campanile M, Arduini D.

J Obstet Gynaecol. 2017 Apr;37(3):296-304. doi: 10.1080/01443615.2016.1239069. Epub 2016 Dec 6.

PMID:
27923290
14.

Telemedicine to Improve Access to Specialist Care in Fetal Heart Rate Monitoring: Analysis of 17 Years of TOCOMAT Network Clinical Activity.

Tagliaferri S, Esposito FG, Ippolito A, Mereghini F, Magenes G, Martinelli P, Campanile M, Signorini MG.

Telemed J E Health. 2017 Mar;23(3):226-232. doi: 10.1089/tmj.2016.0087. Epub 2016 Sep 19.

PMID:
27642802
15.

Computerized analysis of fetal heart rate variability signal during the stages of labor.

Annunziata ML, Tagliaferri S, Esposito FG, Giuliano N, Mereghini F, Di Lieto A, Campanile M.

J Obstet Gynaecol Res. 2016 Mar;42(3):258-65. doi: 10.1111/jog.12908. Epub 2016 Jan 20.

PMID:
26787219
16.

Evaluation of the Acceleration and Deceleration Phase-Rectified Slope to Detect and Improve IUGR Clinical Management.

Tagliaferri S, Fanelli A, Esposito G, Esposito FG, Magenes G, Signorini MG, Campanile M, Martinelli P.

Comput Math Methods Med. 2015;2015:236896. doi: 10.1155/2015/236896. Epub 2015 Dec 8.

17.

Role of glutamate receptors in tetrabrominated diphenyl ether (BDE-47) neurotoxicity in mouse cerebellar granule neurons.

Costa LG, Tagliaferri S, Roqué PJ, Pellacani C.

Toxicol Lett. 2016 Jan 22;241:159-66. doi: 10.1016/j.toxlet.2015.11.026. Epub 2015 Nov 27.

18.

IUGR management: new perspectives.

Giuliano N, Annunziata ML, Tagliaferri S, Esposito FG, Imperato OC, Campanile M, Signorini MG, Di Lieto A.

J Pregnancy. 2014;2014:620976. doi: 10.1155/2014/620976. Epub 2014 Dec 9.

19.

A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity.

Costa LG, de Laat R, Tagliaferri S, Pellacani C.

Toxicol Lett. 2014 Oct 15;230(2):282-94. doi: 10.1016/j.toxlet.2013.11.011. Epub 2013 Nov 20. Review.

20.

Governance of innovation and appropriateness of hospitalization for high-risk pregnancy: the TOCOMAT system.

Tagliaferri S, Ippolito A, Cuccaro P, Annunziata ML, Campanile M, Di Lieto A.

Telemed J E Health. 2013 Jul;19(7):542-8. doi: 10.1089/tmj.2012.0205. Epub 2012 Nov 12.

PMID:
23146064
21.

Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.

Kauss T, Gaudin K, Gaubert A, Ba B, Tagliaferri S, Fawaz F, Fabre JL, Boiron JM, Lafarge X, White NJ, Olliaro PL, Millet P.

Int J Pharm. 2012 Oct 15;436(1-2):624-30. doi: 10.1016/j.ijpharm.2012.07.030. Epub 2012 Jul 30.

22.

Synergistic interactions between PBDEs and PCBs in human neuroblastoma cells.

Pellacani C, Tagliaferri S, Caglieri A, Goldoni M, Giordano G, Mutti A, Costa LG.

Environ Toxicol. 2014 Apr;29(4):418-27. doi: 10.1002/tox.21768. Epub 2012 Mar 20.

PMID:
22434561
23.

Fetal vibroacoustic stimulation in computerized cardiotocographic analysis: the role of short-term variability and approximate entropy.

Annunziata ML, Scala M, Giuliano N, Tagliaferri S, Imperato OC, Esposito FG, Campanile M, Di Lieto A.

J Pregnancy. 2012;2012:814987. doi: 10.1155/2012/814987. Epub 2012 Jan 16.

24.

Inter- and intra-subject variability of kinetics of airway exhalation and deposition of particulate matter in indoor polluted environments.

Goldoni M, Acampa O, Longo S, Poli D, Tagliaferri S, Corradi M, Renzulli FS, Mutti A.

Int J Hyg Environ Health. 2012 Apr;215(3):312-9. doi: 10.1016/j.ijheh.2011.10.012. Epub 2011 Dec 3.

PMID:
22137158
25.

Dose-response or dose-effect curves in in vitro experiments and their use to study combined effects of neurotoxicants.

Goldoni M, Tagliaferri S.

Methods Mol Biol. 2011;758:415-34. doi: 10.1007/978-1-61779-170-3_28. Review.

PMID:
21815082
26.

Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites.

Verzelloni E, Pellacani C, Tagliazucchi D, Tagliaferri S, Calani L, Costa LG, Brighenti F, Borges G, Crozier A, Conte A, Del Rio D.

Mol Nutr Food Res. 2011 May;55 Suppl 1:S35-43. doi: 10.1002/mnfr.201000525. Epub 2011 Jan 14.

PMID:
21240902
27.

Low concentrations of the brominated flame retardants BDE-47 and BDE-99 induce synergistic oxidative stress-mediated neurotoxicity in human neuroblastoma cells.

Tagliaferri S, Caglieri A, Goldoni M, Pinelli S, Alinovi R, Poli D, Pellacani C, Giordano G, Mutti A, Costa LG.

Toxicol In Vitro. 2010 Feb;24(1):116-22. doi: 10.1016/j.tiv.2009.08.020. Epub 2009 Aug 29.

PMID:
19720130
28.

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines.

La Monica S, Galetti M, Alfieri RR, Cavazzoni A, Ardizzoni A, Tiseo M, Capelletti M, Goldoni M, Tagliaferri S, Mutti A, Fumarola C, Bonelli M, Generali D, Petronini PG.

Biochem Pharmacol. 2009 Sep 1;78(5):460-8. doi: 10.1016/j.bcp.2009.04.033. Epub 2009 May 7.

PMID:
19427302
29.

Polybrominated diphenyl ether (PBDE) flame retardants: environmental contamination, human body burden and potential adverse health effects.

Costa LG, Giordano G, Tagliaferri S, Caglieri A, Mutti A.

Acta Biomed. 2008 Dec;79(3):172-83. Review.

PMID:
19260376
30.

Exposure to low levels of hexavalent chromium: target doses and comparative effects on two human pulmonary cell lines.

Caglieri A, Goldoni M, De Palma G, Mozzoni P, Gemma S, Vichi S, Testai E, Panico F, Corradi M, Tagliaferri S, Costa LG.

Acta Biomed. 2008;79 Suppl 1:104-15.

PMID:
18924316
31.

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.

Colla S, Tagliaferri S, Morandi F, Lunghi P, Donofrio G, Martorana D, Mancini C, Lazzaretti M, Mazzera L, Ravanetti L, Bonomini S, Ferrari L, Miranda C, Ladetto M, Neri TM, Neri A, Greco A, Mangoni M, Bonati A, Rizzoli V, Giuliani N.

Blood. 2007 Dec 15;110(13):4464-75. Epub 2007 Sep 11. Erratum in: Blood. 2008 Sep 1;112(5):2170..

PMID:
17848618
32.

Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.

Giuliani N, Morandi F, Tagliaferri S, Lazzaretti M, Donofrio G, Bonomini S, Sala R, Mangoni M, Rizzoli V.

Cancer Res. 2007 Aug 15;67(16):7665-74.

33.

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients.

Giuliani N, Morandi F, Tagliaferri S, Lazzaretti M, Bonomini S, Crugnola M, Mancini C, Martella E, Ferrari L, Tabilio A, Rizzoli V.

Blood. 2007 Jul 1;110(1):334-8. Epub 2007 Mar 19.

PMID:
17371942
34.

Targeting pathways mediating bone disease.

Giuliani N, Morandi F, Tagliaferri S, Rizzoli V.

Curr Pharm Biotechnol. 2006 Dec;7(6):423-9. Review.

PMID:
17168658
35.

CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival.

Giuliani N, Bonomini S, Romagnani P, Lazzaretti M, Morandi F, Colla S, Tagliaferri S, Lasagni L, Annunziato F, Crugnola M, Rizzoli V.

Haematologica. 2006 Nov;91(11):1489-97.

36.

Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients.

Giuliani N, Morandi F, Tagliaferri S, Colla S, Bonomini S, Sammarelli G, Rizzoli V.

Blood. 2006 Jan 15;107(2):841-2. No abstract available.

PMID:
16401825

Supplemental Content

Loading ...
Support Center